Please login to the form below

Not currently logged in
Email:
Password:

Lansons to offer health innovation start-up support

Partners with The Health-Tech Innovation LABS on new website

Lansons Health Innovators TVLansons has launched a global multichannel online platform to support the health innovation community and facilitate routes to market for start-ups.

The reputation management consultancy's Healthinnovators.tv will sharing help unblock access to funds and markets and developing multi-stakeholder partnerships.

Tina Woods, head of Lansons Health, said: “The health sector is in the midst of a significant and exciting transformation as technology continues to empower consumers. Healthinnovators.tv will provide a platform to support new players and ideas which are evolving in an increasing complex health ecosystem.”

The platform is a collaboration with The Health-Tech Innovation LABS, a group of businesses that provide health technology innovation services.

Barry Shrier, CEO of The Health-Tech Innovation LABS, said: "Citizens and nations around the world are experiencing greater healthcare challenges than ever before; with for example our ageing populations and economic cutbacks everywhere. 

“We must therefore accelerate innovation in healthcare technology; to enable doctors to deliver more for less. This exciting and important new initiative - Healthinnovators.tv - will make a powerful contribution to what is the ultimate good cause: saving lives and reducing suffering." 

With Healthinnovators.tv the partners aim to reach the general public as well as those in healthcare to communicate about health innovation and people-powered health.

Article by
Dominic Tyer

28th January 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics